Hyperglycemia is a medical condition in which an individual has an abnormally high level of glucose in their blood. It is a common symptom of diabetes, a chronic endocrine disorder that affects the body's ability to produce or use insulin. Hyperglycemia can lead to serious health complications, including heart disease, stroke, and kidney failure. Treatment for hyperglycemia typically involves lifestyle changes, such as diet and exercise, as well as medications to help control blood sugar levels.
The hyperglycemia market is a subset of the endocrinology market, which focuses on the diagnosis and treatment of endocrine disorders. This market is driven by the increasing prevalence of diabetes and other endocrine disorders, as well as the development of new treatments and technologies. Companies in this market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. Show Less Read more
